- Home
- MMLP vs COEP Comparison
MMLP vs COEP Comparison
Compare MMLP & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMLP | COEP |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.4M | 100.4M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | MMLP | COEP |
|---|---|---|
| Price | $2.87 | $11.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.5K | ★ 44.8K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,653,009,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.65 | N/A |
| 52 Week Low | $2.21 | $6.32 |
| 52 Week High | $3.90 | $21.41 |
Technical Indicators
Market Signals| Indicator | MMLP | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 52.63 | 41.31 |
| Support Level | $2.50 | $10.74 |
| Resistance Level | $3.05 | $12.71 |
| Average True Range (ATR) | 0.14 | 0.80 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 65.96 | 37.26 |
Price Performance
Historical ComparisonAbout MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.